Journal of Diabetes Research / 2020 / Article / Tab 1 / Clinical Study
Restoration of Foveal Bulge after Resolution of Diabetic Macular Edema with Coexisting Serous Retinal Detachment Table 1 Baseline characteristics of diabetic macular edema eyes with coexisting serous retinal detachment in foveal bulge (+) group and foveal bulge (-) group.
Foveal bulge (+) ( ) Foveal bulge (−) ( ) Mean age (SD) (years) 54.64 (8.83) 56.67 (13.50) 0.134† Mean IOP (SD) (mmHg) 14.12 (2.19) 15.07 (2.73) 0.132† Mean time since diagnosis of DM (SD) (years) 7.72 (3.71) 9.04 (5.42) 0.568† Mean duration of DME before IVR (SD) (months) 7.99 (6.43) 10.50 (7.43) 0.161† Mean HbA1C (SD) (%) 8.09 (1.30) 8.66 (2.60) 0.761† Diabetic retinopathy severity ( (%)) 0.746‡ NPDR 15 (60.0%) 15 (55.6%) PDR 10 (40.0%) 12 (44.4%) Photocoagulation treatment ( (%)) 13 (52.0%) 14 (51.9%) 0.991‡ Mean baseline BCVA (SD) (logMAR/Snellen VA) 0.46 (0.24)/≈20/57.7 0.52 (0.15)/≈20/66.2 0.135† Mean baseline CFT (SD) (μ m) 533.84 (178.69) 587.37 (235.75) 0.589† Mean baseline SRDH (SD) (μ m) 214.96 (85.01) 308.11 (186.27) 0.040†
† Unpaired Mann-Whitney test; ‡ Chi-square test. IOP: intraocular pressure; DM: diabetic mellitus; IVR: intravitreal injection of ranibizumab; HbA1c: glycosylated hemoglobin; NPDR: nonproliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; BCVA: best-corrected visual acuity; Snellen VA: Snellen visual acuity; CFT: central foveal thickness; SRDH: height of serous retinal detachment; SD standard deviation.